SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase (COIN) is trending due to polarized community reactions to its recent Super Bowl commercial, with sentiment sharply divided on its effectiveness amid broader discussions of significant crypto market volatility. The debate continues on whether the stock has found a bottom or is poised for further declines, alongside anticipation for upcoming earnings.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is drawing significant attention following news of its extended $250 million capital runway through 2028, which many believe secures its operations and removes dilution concerns. The community is sharply divided, with bulls anticipating a short squeeze and another historic surge in the blockchain and molecular-marker technology stock, while skeptics argue it remains a "dilution machine" without sustained product revenue.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as the Super Bowl drives massive betting volume and user engagement, with the community actively debating the company's expanding prediction market offerings and the broader sector's evolving regulatory landscape, all ahead of its anticipated earnings report.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after abruptly ceasing its compounded GLP-1 weight-loss pill offering amid intensified FDA scrutiny and legal threats, sparking widespread debate about the company's regulatory risks and strategic direction. The community is sharply divided, with bears pointing to management's judgment and potential lawsuits, while bulls emphasize the removal of legal overhang and the broader telehealth platform's potential for recovery and growth, especially with the upcoming Super Bowl ad.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Community excitement for TG Therapeutics is surging following Christina Applegate's Super Bowl commercial for Briumvi, which is expected to drive substantial patient awareness and market adoption. The authentic endorsement is viewed as a significant catalyst, further differentiating Briumvi amidst competitor safety concerns.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is garnering significant attention following FDA acceptance of its NDA for CTx-1301, a potentially game-changing ADHD treatment, as the community eagerly awaits impending US patent news, fueling speculation of substantial market revaluation due to its low float.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

PZZA is trending due to persistent buyout speculation, with community sentiment driven by reports of private equity offers at a premium to its perceived undervalued share price, alongside discussions of activist investor interest and its attractive dividend yield.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as futures indicate strong bullish momentum leading into the week, while the community is widely discussing the Super Bowl halftime show's perceived, albeit speculative, impact on market sentiment alongside anticipation for upcoming jobs and inflation reports.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

Jerry The Turtle ($JYAI), an AI memecoin backed by Matt Furie, is trending with strong community enthusiasm following new exchange listings on platforms like Bitget and KuCoin Alpha, a recent developer update to counter selling pressure, and an ongoing 12-week marketing campaign including a new podcast and a Crypto Banter partnership, with many anticipating it to be the "next PEPE" and aspiring for Tier 1 exchange listings.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - VR PRF PERPETUAL USD 100 - Ser A

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred

STRC is trending as it maintains its position around $100 par value, buoyed by its attractive variable dividend rate of 11.25%, with the community actively debating its role in funding MSTR's Bitcoin strategy and its viability as a high-yield income instrument.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Senseonics (SENS) Rating Upgrade to Buy

Senseonics (SENS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Senseonics (SENS) Moves 5.3% Higher: Will This Strength Last?

Senseonics (SENS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval

Senseonics stock jumps after Eversense 365 wins CE Mark, expanding Europe access for its one-year CGM and strengthening the long-term growth outlook.

Senseonics (NYSE:SENS) Stock Price Up 3.9% - Time to Buy?

Senseonics (NYSE:SENS) Shares Up 3.9% - Should You Buy...

SENS Stock Up as Eversense 365 Enters AID Market With twiist System

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

<ul class="summary-bullets"><li>Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.&nbsp;</li><li>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, the company said.</li><li>The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management.</li></ul>Shares of Senseonics Holdings, Inc. (SENS) closed over 8% higher on Thursday after the company announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.Senseonics said that alongside Sequel, it has launched the integration of the products with the first patients having received a Sequel twiist AID system paired with the Eversense 365 CGM.Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.The company’s shares were up 0.14% in after-market hours at the time of writing.<h2 class="st-heading-2">World’s First AID Integration</h2>Combining twiist with Senseonics’s Eversense 365 marks the first time when a one-year CGM system has been integrated with an AID, representing a major milestone in long-term diabetes management by reducing the need for regular sensor changes and re-pairing, while maintaining exceptional accuracy, the company said.“Patients and providers want reliable, long-term automated glucose readings and we’ve taken a major step forward in simplifying and personalizing diabetes management by integrating Eversense 365’s One Year CGM system with the twiist AID system for patients that require insulin,” Goodnow said.Meanwhile, Alan Lotvin, CEO of Sequel MedTech said that diabetes management is deeply personal, and no single approach works for everyone. “Our focus on personalization means Sequel is committed to creating choice for people living with diabetes; integration with the Eversense CGM is an important step in this journey, enabling more people to experience the precision and confidence that twiist AID system brings to diabetes management,” he added.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_09_at_3_22_54_AM_png_4f2919b8d5.webp" alt="On Stocktwits, retail sentiment around SENS stock stayed in the ‘bullish’ territory over the past day amid ‘high’ message volumes." width="1303" height="157"></figure><a href="https://stocktwits.com/symbol/SENS">Shares of SENS</a> have lost over 17% of their value in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

An Asian teenager with type 1 diabetes uses an at home glucometer to test his blood sugar levels. | Image source: Getty Images

SENS Shares Surge After First Commercial Patients Use AID-Integrated Continuous Glucose Monitor System

Senseonics announced the first commercial usage of its year-long implantable Eversense 365 Continuous Glucose Monitor (CGM) with Sequel MedTech’s Automated Insulin Delivery (AID) system.

Equity

Senseonics Holdings, Inc. (NYSE:SENS) Receives Average Rating of "Buy" from Analysts

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) has been given an average recommendation of "Buy" by the six analysts that are covering the company, MarketBeat.com reports. One equities...

Maven Securities LTD Takes Position in Senseonics Holdings, Inc. $SENS

Maven Securities LTD acquired a new stake in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and...

Hood River Capital Management LLC Invests $3.78 Million in Senseonics Holdings, Inc. $SENS

Hood River Capital Management LLC acquired a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) during the second quarter, according to the company in its most recent...

Vistagen Appoints Nick Tressler as Chief Financial Officer

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product...

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

SENS
Senseonics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SENS News

SENSSenseonics Holdings Inc